Updated Wednesday, Nov. 4, 2026. Anthropic filed its S-1 publicly on Monday, Oct. 26, and plans to list on Nasdaq under the ticker ANT. The price range, share count and listing date are not set yet. Here is where things stand, then what the prospectus shows.
🆕 Update, Wed., Nov. 4, 2026: the amended S-1/A (filed Nov. 2)
- Revenue: $33.2 billion in the first nine months of 2026, vs. $4.6 billion in all of 2025. Q3 alone: $17.0 billion, about 47% above Q2 ($11.6B).
- Profitability: a nine-month operating loss of $1.3 billion (Q2 operating profit of $974M, Q3 operating loss of $567M). The $104B net loss is mostly a $94.3B non-cash fair-value charge.
- Cash: $131.8 billion in cash and short-term investments; about $895B in signed contracts, mostly computing.
- Price range and date: still blank. Nov. 10 is the earliest possible roadshow start under SEC practice — not a confirmed date.
- Retail access: part of the offering is planned for individual investors through six brokers, including Robinhood, Fidelity and Charles Schwab.
- Control: Class A shares (one vote) are offered; a Long-Term Benefit Trust and the founders’ entity elect the board.
Source: StockTitan summary of the S-1/A filed Nov. 2, 2026. Not investment advice.
Anthropic’s S-1 filing turns the AI boom’s most-watched private company into a public-market test case. The numbers are extraordinary in both directions: $16.3 billion of revenue in the first half of 2026, up from $1.2 billion a year earlier, alongside an $80.7 billion net loss and hundreds of billions in compute commitments. With reported valuation talk of $1.5 to $2 trillion and a raise that could exceed $100 billion, here is how to read the prospectus, how retail investors can get access, and what could go wrong.
The prospectus in ten numbers
| Metric | Figure | Why it matters |
|---|---|---|
| H1 2026 revenue | $16.3B (vs. $1.2B) | About 13x year-over-year growth |
| Q3 2026 revenue (reported) | ≈ $16.8B | ≈ $67B annualized run rate |
| H1 net loss | $80.7B | ≈ $72B is a non-cash charge tied to financing instruments |
| Cash (June 30) | $112.4B | Ample runway |
| Minimum future compute payments | ≈ $245B | Fixed obligations regardless of demand |
| $100K+ customers | 11,900+ (vs. 950) | Enterprise adoption is broadening |
| Net revenue retention | ≈ 900% | Existing customers are expanding spend rapidly |
| Top-5 customer share | ≈ 25% of revenue | Concentration risk |
| Dividends | None expected | A pure growth bet |
| Lead underwriters | Goldman Sachs, Morgan Stanley | Price range not set yet |
Source: S-1 as reported by Investing.com.
The charts and screeners behind our market coverage. Create a free account; if you later choose a paid plan you get a $15 discount.
Open TradingView → · Affiliate linkValuation math
At $1.5 trillion, investors would pay roughly 22x annualized revenue; at $2 trillion, about 30x. If Anthropic reaches its reported 2028 target of $190–200 billion in revenue, the multiple on a $1.5 trillion valuation compresses to about 8x. The bull case therefore requires not just growth, but growth roughly on plan, while funding compute obligations that dwarf current revenue.
Bolsa al Día calculation using reported figures. Illustrative.
How retail investors can get exposure
- IPO allocation: some U.S. brokerages let eligible clients submit a conditional indication of interest, typically with a share count and price cap. Hot deals are heavily oversubscribed; most retail requests receive little or nothing.
- Day-one trading: once ANT lists on Nasdaq (the date is not confirmed; reports point to a roadshow around the week of Nov. 9 and a debut before Thanksgiving), anyone with a brokerage account can buy. Use limit orders; opening prints on high-profile IPOs can be far above the offer price.
- Indirect exposure: Amazon and Alphabet are strategic investors and cloud partners; Broadcom and Nvidia are major suppliers. Their exposure is diluted by other businesses but comes with existing profits.
- Index inclusion: eventual entry into the Nasdaq-100 or S&P 500 would bring passive ownership, but timing depends on each index’s rules.
- Tax-advantaged accounts: if you plan to hold a volatile IPO for years, an IRA can shield future gains from annual taxation.
Fundamentals, charts, valuation and side-by-side comparisons of stocks, ETFs and funds worldwide, including Colombian ADRs. There is a free plan to start.
Try Koyfin → · Affiliate linkHow to buy Anthropic (ANT) stock: step by step
- Open or fund a U.S. brokerage account before the listing date; transfers can take a few days.
- Check whether your broker offers IPO access. Some let eligible clients request shares at the offer price; allocations in a deal this popular are likely small or zero.
- Wait for the price range. It appears in an amended S-1 before the roadshow and tells you the valuation the company is asking for.
- On listing day, use a limit order. High-profile IPOs often open well above the offer price and can swing sharply in the first hours.
- Size the position for volatility. A newly listed, loss-making company can move 10% or more in a day; lockup expirations later add supply.
This is general information about how IPOs work, not a recommendation to buy or sell.
Five risks worth more attention than they are getting
Compute is the product’s cost of goods. Revenue growth means little if each dollar of revenue requires a dollar or more of compute.
Roughly $245B in minimum future payments are owed whether or not demand keeps compounding.
March 2026 web-traffic share: ChatGPT about 50%, Gemini about 22%, Claude about 10%. Enterprise strength may offset consumer share, but rivals have deeper balance sheets.
A public benefit corporation whose Long-Term Benefit Trust can appoint a majority of the board. Public shareholders will have less control than in a typical company.
Lockup expirations for employees and early investors can add significant selling pressure in the months after listing.
Anthropic’s growth is real and its enterprise traction is unusually strong, but a $1.5–2 trillion price tag leaves little room for execution risk in a business defined by massive fixed costs and well-funded competitors. Mega-IPOs have a mixed short-term record: Facebook listed at $38 in 2012 and fell roughly by half in the following months before becoming a long-term winner. Our view is that the debut will say more about investor appetite for AI than about Anthropic’s intrinsic value. For most investors, sizing matters more than timing: a small position, entered with limit orders and the patience to sit through lockup-driven volatility, is more defensible than chasing the opening print.
Anthropic IPO: frequently asked questions
When is the Anthropic IPO?
No date is set. The amended S-1/A was filed on Nov. 2, 2026; Nov. 10 is the earliest possible roadshow start, and pricing would follow the roadshow. The price range is still blank.
How much revenue does Anthropic make?
$33.2 billion in the first nine months of 2026, including $17.0 billion in the third quarter, according to the amended S-1/A.
Where can I buy Anthropic IPO shares?
The filing plans a retail allocation through six brokers, including Robinhood, Fidelity and Charles Schwab. After listing, ANT would trade on Nasdaq like any stock.
What will Anthropic’s stock ticker be?
Anthropic plans to list on Nasdaq under the ticker ANT.
How much will Anthropic shares cost?
The price range has not been published yet. It will appear in an amended S-1 before the roadshow. Valuation talk in the press ranges from $1.5 trillion to $2 trillion, versus a $965 billion private valuation in May 2026.
Can retail investors buy Anthropic at the IPO price?
Possibly, but in small amounts. Bloomberg reported that 15% to 20% of shares could go to retail investors through brokers and wealth managers; otherwise anyone can buy once ANT starts trading.
Is Anthropic profitable?
No. The S-1 shows $16.3 billion of revenue and an $80.7 billion net loss in the first half of 2026, most of it a non-cash charge tied to financing instruments.
Will Anthropic pay dividends?
The company does not expect to pay dividends in the foreseeable future.
Affiliate disclosure: some links on this page are affiliate links. If you sign up or subscribe through them, Bolsa al Día may earn a commission at no extra cost to you. This never affects our analysis. Learn more.
Leave a Reply